Market Summary
USD35.19-0.10
Market Closed-0.28%
XRAY Stock Price
XRAY RSI Chart
XRAY Valuation
XRAY Price/Sales (Trailing)
XRAY Profitability
XRAY Fundamentals
XRAY Revenue
XRAY Earnings
Price Action
52 Week Range
26.4843.24
(Low)(High)
Last 7 days
-3.7%
Last 30 days
-5.4%
Last 90 days
-9.4%
Trailing 12 Months
10.6%
XRAY Financial Health
XRAY Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for XRAY
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-09-12 | Campion Simon D | sold (taxes) | -1,107,120 | 36.65 | -30,208 | president, ceo & member of bod |
2023-08-09 | Brackett Erania | sold (taxes) | -9,502 | 38.47 | -247 | svp, chief marketing officer |
2023-08-09 | Frohning Andrea L. | acquired | - | - | 7,798 | svp, chro |
2023-07-17 | Johnson Robert Anthony | acquired | - | - | 330 | svp, chief supply chain office |
2023-07-14 | VARON LESLIE F | acquired | - | - | 49.884 | - |
2023-07-14 | Coleman Glenn | acquired | - | - | 228 | executive vp & cfo |
2023-07-14 | Vergis Janet S. | acquired | - | - | 41.45 | - |
2023-07-14 | HOLDEN BETSY D | acquired | - | - | 93.091 | - |
2023-07-14 | Wenzel Ilse Dorothea | acquired | - | - | 41.45 | - |
2023-07-14 | KRAEMER HARRY M JANSEN JR | acquired | - | - | 75.005 | - |
Which funds bought or sold XRAY recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-13 | CGC Financial Services, LLC | new | - | 7,539 | 7,539 | -% |
2023-09-12 | Farther Finance Advisors, LLC | added | 67.83 | 3,988 | 9,605 | -% |
2023-08-28 | Willow Creek Wealth Management Inc. | added | 0.06 | 9,678 | 508,534 | 0.07% |
2023-08-28 | DT Investment Partners, LLC | unchanged | - | -25.00 | 1,035 | -% |
2023-08-25 | Gould Capital, LLC | unchanged | - | 134 | 7,244 | 0.01% |
2023-08-23 | HEADINVEST, LLC | reduced | -32.83 | -349,900 | 690,313 | 0.15% |
2023-08-23 | Stonebridge Capital Advisors LLC | unchanged | - | 74.00 | 4,002 | -% |
2023-08-22 | COMERICA BANK | sold off | - | - | - | -% |
2023-08-21 | JOHN G ULLMAN & ASSOCIATES INC | reduced | -2.67 | -41,158 | 4,886,840 | 0.75% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | reduced | -1.88 | - | 773,000 | 0.01% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Schedule 13G FIlings of Dentsply Sirona
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 13, 2023 | generation investment management llp | 2.21% | 4,747,746 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 11.69% | 25,121,756 | SC 13G/A | |
| Feb 08, 2023 | nuance investments, llc | 5.88% | 12,642,319 | SC 13G | |
| Feb 03, 2023 | blackrock inc. | 7.9% | 16,978,584 | SC 13G/A | |
| Mar 09, 2022 | blackrock inc. | 10.9% | 23,745,567 | SC 13G/A | |
| Feb 14, 2022 | generation investment management llp | 5.26% | 11,504,992 | SC 13G/A | |
| Feb 09, 2022 | vanguard group inc | 10.91% | 23,855,927 | SC 13G/A | |
| Feb 04, 2022 | artisan partners limited partnership | 5.2% | 11,339,948 | SC 13G/A | |
| Feb 01, 2022 | blackrock inc. | 8.1% | 17,700,553 | SC 13G/A | |
| Dec 30, 2021 | generation investment management llp | 5.26% | 11,504,992 | SC 13G |
Recent SEC filings of Dentsply Sirona
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Sep 13, 2023 | 4 | Insider Trading | |
| Sep 13, 2023 | 8-K | Current Report | |
| Aug 10, 2023 | 4 | Insider Trading | |
| Aug 10, 2023 | 4 | Insider Trading | |
| Aug 07, 2023 | 10-K/A | Annual Report | |
| Aug 07, 2023 | 10-Q | Quarterly Report | |
| Aug 07, 2023 | 10-Q/A | Quarterly Report | |
| Aug 02, 2023 | 8-K | Current Report | |
| Jul 26, 2023 | 3 | Insider Trading | |
| Jul 17, 2023 | 4 | Insider Trading |
Peers (Alternatives to Dentsply Sirona)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
SYK | 109.7B | 19.5B | 5.69% | 32.97% | 40.5 | 5.64 | 10.36% | 30.30% |
MDT | 108.4B | 31.6B | 1.36% | -7.86% | 29.89 | 3.44 | 1.57% | -30.40% |
ISRG | 102.6B | 6.7B | 4.79% | 48.19% | 71.98 | 15.39 | 11.75% | -0.66% |
BDX | 71.3B | 19.0B | -2.82% | 6.66% | 44.09 | 3.79 | 0.46% | -5.24% |
EW | 43.7B | 5.7B | -4.65% | -17.80% | 31.48 | 7.73 | 5.64% | -4.53% |
| MID-CAP | ||||||||
PEN | 10.1B | 937.8M | 4.57% | 35.10% | 345.25 | 10.72 | 16.30% | 250.21% |
SWAV | 7.7B | 616.6M | -5.28% | -28.68% | 31.46 | 12.45 | 69.52% | 343.68% |
GMED | 5.3B | 1.1B | -3.27% | -11.90% | 25.23 | 4.84 | 12.63% | 50.85% |
IRTC | 2.7B | 452.1M | -15.03% | -38.95% | -27.51 | 6.04 | 24.99% | 24.09% |
TNDM | 1.4B | 790.3M | -24.48% | -59.71% | -6.39 | 1.81 | 3.21% | -1604.53% |
| SMALL-CAP | ||||||||
AVNS | 952.1M | 780.7M | -7.16% | -11.41% | -26.45 | 1.22 | 4.68% | -510.17% |
CSII | 839.3M | 239.8M | 0.70% | 0.15% | -22.16 | 3.5 | -4.74% | -31.15% |
SILK | 637.3M | 162.9M | -22.73% | -61.80% | -12.05 | 3.91 | 42.67% | 12.82% |
BLFS | 551.7M | 162.2M | 18.78% | -45.96% | -6.56 | 3.4 | 9.71% | 12.37% |
Dentsply Sirona News
Returns for XRAY
Cumulative Returns on XRAY
-1.6%
10-Year Cumulative Returns
-6.6%
7-Year Cumulative Returns
-1.1%
5-Year Cumulative Returns
-8.1%
3-Year Cumulative Returns
Risks for XRAY
What is the probability of a big loss on XRAY?
71.9%
Probability that Dentsply Sirona stock will be more than 20% underwater in next one year
52.3%
Probability that Dentsply Sirona stock will be more than 30% underwater in next one year.
45.4%
Probability that Dentsply Sirona stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does XRAY drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Dentsply Sirona was unfortunately bought at previous high price.
Drawdowns
Financials for Dentsply Sirona
Income Statement (Last 12 Months)(In Thousands)
| Income Statement (Last 12 Months) | (In Thousands) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Revenue | 0.1% | 3,936,000 | 3,931,000 | 3,922,000 | 4,042,000 | 4,135,000 | 4,174,000 | 4,231,000 | 4,204,000 | 4,047,000 | 3,484,000 | 3,339,000 | 3,374,500 | 3,453,600 | 3,964,000 | 4,029,200 | 3,977,400 | 3,943,700 | 3,976,400 | 3,986,300 | 4,017,600 | 4,098,400 |
| Gross Profit | -1.5% | 2,094,000 | 2,125,000 | 2,127,000 | 2,214,000 | 2,275,000 | 2,289,000 | 2,347,000 | 2,310,000 | 2,173,000 | 1,760,000 | 1,656,000 | 1,699,600 | 1,781,600 | 2,140,400 | 2,165,100 | 2,079,300 | 2,041,400 | 2,053,400 | 2,067,800 | 2,136,300 | 2,219,200 |
| S&GA Expenses | 0.4% | 1,635,000 | 1,629,000 | 1,589,000 | 1,564,000 | 1,558,000 | 1,541,000 | 1,551,000 | 1,547,000 | 1,465,000 | 1,331,000 | 1,302,000 | 1,253,900 | 1,340,200 | 1,512,100 | 1,587,000 | 1,695,200 | 1,714,400 | 1,715,700 | 1,719,000 | 1,707,800 | 1,719,800 |
| R&D Expenses | 2.3% | 179,000 | 175,000 | 174,000 | 180,000 | 178,000 | 176,000 | 171,000 | 160,000 | 150,000 | 127,000 | 123,000 | 113,333 | 112,000 | 144,000 | 143,000 | - | - | - | - | - | - |
| EBITDA | 100.0% | - | -972,000 | -866,000 | -725,000 | 627,000 | - | 970,000 | - | - | 608,100 | 322,000 | 315,400 | 347,500 | 512,000 | 697,200 | 648,500 | 576,800 | -631,500 | - | - | - |
| EBITDA Margin | 100.0% | - | -0.25* | -0.22* | -0.17* | 0.15* | - | 0.23* | - | - | 0.17* | 0.10* | 0.09* | 0.10* | 0.13* | 0.17* | 0.16* | 0.15* | -0.16* | - | - | - |
| Interest Expenses | 7.8% | 83,000 | 77,000 | 70,000 | 62,000 | 62,000 | 62,000 | 64,000 | 57,000 | 57,000 | 53,000 | 45,000 | 39,000 | 31,600 | 28,600 | 30,000 | 32,100 | 35,200 | 36,800 | 37,000 | 37,500 | 37,600 |
| Earnings Before Taxes | -3.8% | -1,215,000 | -1,170,000 | -1,055,000 | -907,000 | 447,000 | 487,000 | 545,000 | 518,000 | 462,000 | 217,000 | -50,000 | -48,900 | 600 | 162,200 | 338,000 | 285,700 | 210,900 | -999,000 | -958,000 | -1,748,700 | -1,682,800 |
| EBT Margin | 100.0% | - | -0.30* | -0.27* | -0.21* | 0.11* | - | 0.13* | 0.13* | 0.12* | 0.06* | -0.02* | -0.01* | 0.00* | 0.04* | 0.09* | 0.07* | - | - | - | - | - |
| Net Income | 1.2% | -1,029,000 | -1,042,000 | -950,000 | -816,000 | 345,000 | 368,000 | 411,000 | 397,000 | 360,000 | 172,000 | -74,000 | -76,700 | -38,700 | 89,700 | 262,900 | 162,400 | 105,400 | -1,053,000 | -1,011,000 | -1,663,200 | -1,600,600 |
| Net Income Margin | 100.0% | - | -0.26* | -0.24* | -0.19* | 0.09* | - | 0.10* | 0.10* | 0.09* | 0.05* | -0.02* | -0.02* | -0.01* | 0.02* | 0.07* | 0.04* | - | - | - | - | - |
| Free Cashflow | -100.0% | - | 254,000 | 368,000 | 375,000 | 266,000 | - | 515,000 | - | - | 607,000 | 548,000 | 547,800 | 499,800 | 470,500 | 509,800 | 353,200 | 319,700 | 291,500 | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Assets | -0.3% | 7,650 | 7,673 | 7,643 | 7,522 | 8,948 | 9,172 | 9,239 | 9,289 | 9,378 | 9,137 | 9,350 | 8,896 | 8,604 | 8,058 | 8,603 | 8,367 | 8,575 | 8,605 | 8,687 | 8,769 | 8,822 |
| Current Assets | -1.2% | 1,920 | 1,943 | 1,893 | 1,939 | 1,885 | 1,897 | 1,852 | 1,805 | 1,785 | 1,696 | 1,798 | 2,580 | 2,363 | 1,805 | 2,000 | 1,811 | 1,828 | 1,796 | 1,888 | 1,903 | 1,892 |
| Cash Equivalents | -7.2% | 295 | 318 | 365 | 418 | 362 | 374 | 339 | 281 | 332 | 318 | 438 | 1,272 | 1,109 | 236 | 405 | 226 | 250 | 225 | 310 | 233 | 239 |
| Inventory | -0.3% | 657 | 659 | 627 | 592 | 581 | 553 | 515 | 548 | 539 | 1.00 | 476 | 489 | 549 | 591 | 562 | 605 | 608 | 618 | 599 | 672 | 666 |
| Net PPE | 0.3% | 772 | 770 | 761 | 714 | 744 | 771 | 773 | 771 | 769 | 758 | 791 | 772 | 772 | 777 | 802 | 783 | 820 | 854 | 871 | 866 | 858 |
| Goodwill | 0.1% | 2,703 | 2,701 | 2,688 | 2,584 | 3,858 | 3,944 | 3,976 | 4,000 | 4,033 | 3,952 | 3,986 | 3,283 | 3,227 | 3,192 | 3,397 | 3,356 | 3,413 | 3,399 | 3,431 | 3,444 | 3,458 |
| Liabilities | -2.2% | 3,948 | 4,035 | 3,831 | 3,908 | 4,110 | 4,308 | 4,242 | 4,226 | 4,301 | 4,207 | 4,415 | 4,134 | 3,959 | 3,368 | 3,508 | 3,308 | 3,392 | 3,495 | 3,554 | 3,615 | 3,682 |
| Current Liabilities | -7.5% | 1,271 | 1,374 | 1,170 | 1,296 | 1,241 | 1,372 | 1,261 | 1,199 | 1,251 | 1,212 | 1,372 | 1,178 | 763 | 892 | 995 | 869 | 881 | 871 | 1,013 | 1,080 | 1,118 |
| LT Debt, Non Current | -0.1% | 1,841 | 1,842 | 1,826 | 1,737 | 1,807 | 1,872 | 1,913 | 1,925 | 1,946 | 1,923 | 1,978 | 1,930 | 2,183 | 1,421 | 1,433 | 1,404 | 1,441 | 1,545 | 1,565 | 1,575 | 1,587 |
| Shareholder's Equity | 1.9% | 3,706 | 3,638 | 3,811 | 3,613 | 4,838 | 4,864 | 4,997 | 5,063 | 5,034 | 4,890 | 4,935 | 4,720 | 4,608 | 4,649 | 5,048 | 5,059 | 5,183 | 5,110 | 5,083 | 5,154 | 5,140 |
| Retained Earnings | 13.8% | 463 | 407 | 456 | 498 | 1,602 | 1,556 | 1,514 | 1,419 | 1,402 | 1,328 | 1,198 | 1,156 | 1,125 | 1,242 | 1,404 | 1,324 | 1,262 | 1,245 | 1,226 | 1,244 | 1,216 |
| Additional Paid-In Capital | 0.7% | 6,648 | 6,604 | 6,629 | 6,619 | 6,617 | 6,573 | 6,606 | 6,659 | 6,638 | 6,618 | 6,604 | 6,592 | 6,577 | 6,554 | 6,587 | 6,567 | 6,551 | 6,520 | 6,522 | 6,529 | 6,526 |
| Shares Outstanding | -0.4% | 212 | 213 | 215 | 215 | 215 | 217 | 217 | 219 | 218 | 219 | 219 | 219 | 219 | 221 | 221 | 223 | 224 | 223 | 223 | 222 | 225 |
| Minority Interest | -33.3% | -4.00 | -3.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 12.00 | 12.00 | 13.00 |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Cashflow From Operations | -17.1% | 334 | 403 | 517 | 375 | 266 | 93.00 | - | 264 | 485 | 659 | 649 | 691 | 629 | 600 | 639 | 536 | 502 | 474 | 500 | 527 | 565 |
| Share Based Compensation | -12.3% | 57.00 | 65.00 | 59.00 | 41.00 | 49.00 | 46.00 | 48.00 | 65.00 | 60.00 | 50.00 | 47.00 | 52.00 | 51.00 | 67.00 | 66.00 | 56.00 | 46.00 | 21.00 | 21.00 | 22.00 | 36.00 |
| Cashflow From Investing | 7.6% | -122 | -132 | -138 | -109 | -83.00 | -43.00 | -103 | -1,204 | -1,229 | -1,193 | -1,106 | -34.30 | -24.50 | -72.30 | -69.00 | -87.70 | -118 | -220 | -253 | -255 | -254 |
| Cashflow From Financing | 21.5% | -237 | -302 | -329 | -168 | -162 | -10.00 | -53.00 | -68.00 | -105 | 553 | 476 | 389 | 266 | -502 | -472 | -449 | -370 | -329 | -250 | -403 | -343 |
| Dividend Payments | 2.8% | 110 | 107 | 104 | 102 | 99.00 | 94.00 | 92.00 | 90.00 | 88.00 | 88.00 | 88.00 | 88.00 | 86.00 | 84.00 | 81.00 | 79.00 | 78.00 | 79.00 | 79.00 | 79.00 | 80.00 |
| Buy Backs | 0% | 150 | 150 | 150 | 110 | 260 | 260 | 200 | 90.00 | 90.00 | 90.00 | 140 | 240 | 340 | 400 | 260 | 160 | 60.00 | 250 | 250 | 500 | 500 |
XRAY Income Statement
2023-06-30CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
| Income Statement [Abstract] | ||||
| Net sales | $ 1,028 | $ 1,023 | $ 2,006 | $ 1,992 |
| Cost of products sold | 478 | 442 | 937 | 890 |
| Gross profit | 550 | 581 | 1,069 | 1,102 |
| Selling, general, and administrative expenses | 416 | 410 | 832 | 786 |
| Research and development expenses | 49 | 45 | 95 | 90 |
| Restructuring and other costs | 5 | 7 | 64 | 10 |
| Operating income | 80 | 119 | 78 | 216 |
| Other income and expenses: | ||||
| Interest expense, net | 21 | 15 | 40 | 27 |
| Other expense (income), net | 13 | 13 | 20 | 11 |
| Income before income taxes | 46 | 91 | 18 | 178 |
| (Benefit) provision for income taxes | (39) | 18 | (44) | 36 |
| Net income | 85 | 73 | 62 | 142 |
| Less: Net loss attributable to noncontrolling interest | (1) | 0 | (5) | 0 |
| Net income attributable to Dentsply Sirona | $ 86 | $ 73 | $ 67 | $ 142 |
| Net income per common share attributable to Dentsply Sirona: | ||||
| Basic (in dollars per share) | $ 0.41 | $ 0.34 | $ 0.31 | $ 0.66 |
| Diluted (in dollars per share) | $ 0.40 | $ 0.34 | $ 0.31 | $ 0.66 |
| Weighted average common shares outstanding: | ||||
| Basic (in shares) | 211.9 | 214.9 | 213.2 | 215.9 |
| Diluted (in shares) | 213.1 | 215.3 | 214.4 | 216.5 |
XRAY Balance Sheet
2023-06-30CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current Assets: | ||
| Cash and cash equivalents | $ 295 | $ 365 |
| Accounts and notes receivables-trade, net | 670 | 632 |
| Inventories, net | 657 | 627 |
| Prepaid expenses and other current assets | 298 | 269 |
| Total Current Assets | 1,920 | 1,893 |
| Property, plant, and equipment, net | 772 | 761 |
| Operating lease right-of-use assets, net | 191 | 200 |
| Identifiable intangible assets, net | 1,808 | 1,903 |
| Goodwill | 2,703 | 2,688 |
| Other noncurrent assets | 256 | 198 |
| Total Assets | 7,650 | 7,643 |
| Current Liabilities: | ||
| Accounts payable | 265 | 279 |
| Accrued liabilities | 728 | 727 |
| Income taxes payable | 17 | 46 |
| Notes payable and current portion of long-term debt | 261 | 118 |
| Total Current Liabilities | 1,271 | 1,170 |
| Long-term debt | 1,841 | 1,826 |
| Operating lease liabilities | 144 | 149 |
| Deferred income taxes | 261 | 287 |
| Other noncurrent liabilities | 431 | 399 |
| Total Liabilities | 3,948 | 3,831 |
| Commitments and contingencies (Note 14) | ||
| Equity: | ||
| Preferred stock, $1.00 par value; 0.25 million shares authorized; no shares issued | 0 | 0 |
| Common stock, $0.01 par value; 400.0 million shares authorized, and 264.5 million shares issued at June 30, 2023 and December 31, 2022 211.7 million and 215.3 million shares outstanding at June 30, 2023 and December 31, 2022 | 3 | 3 |
| Capital in excess of par value | 6,648 | 6,629 |
| Retained earnings | 463 | 456 |
| Accumulated other comprehensive loss | (620) | (628) |
| Treasury stock, at cost, 52.8 million and 49.3 million shares at June 30, 2023 and December 31, 2022, respectively | (2,788) | (2,649) |
| Total Dentsply Sirona Equity | 3,706 | 3,811 |
| Noncontrolling interests | (4) | 1 |
| Total Equity | 3,702 | 3,812 |
| Total Liabilities and Equity | $ 7,650 | $ 7,643 |
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces. The company also provides dental CAD/CAM products, digital impressions intraoral scanners, mills, and services; and orthodontic products, including high frequency vibration technology device under the name VPro, dentist-directed clear aligner solutions under the name SureSmile, and direct-to-consumer clear aligner solutions under the name Byte; dental implant products, bone regenerative and restorative solutions, and educational programs; and urology catheters and other healthcare-related consumable products. In addition, it offers endodontic products comprising endodontic instruments and materials, drills, filers, sealers, irrigation needles, and other tools or single-use solutions; restorative products that include dental prosthetics, such as artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products; small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers; and dental supplies, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.